Bryan, Texas — According to state and local economic development sources Matica Biotechnology plans to invest $1,650,000.00 to build out 6,200 square feet of new space in Bryan. The company plans to occupy the new space at 8441 Riverside Parkway, Suite 4500 in Bryan, on or about December 1, 2022. According to the company website Matica Biotechnology, Inc. is a contract development and manufacturing organization (CDMO) specializing in the production of virus based cell & gene therapies, vaccines, and other precision medicines for our clients. Our GMP facility is currently under construction in College Station, TX, slated to open in Q3 2021. While our facility may be new, we have assembled an exceptional staff of industry veterans, most with 10 15 years of experience in the production of virus and advanced therapies for some of the most innovative products on market and in the clinic today. With the support of our parent company CHA Biotech, our goal is to establish a streamlined, global manufacturing solution for your viral vector product.

To learn more about Matica Biotechnology, visit http://www.maticabio.com/

Company Contact:
Yun Jeong Song, Chief Executive Officer
https://www.linkedin.com/in/yun-jeong-song-30353b25/
979-321-7500

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved